Table 7.
Group 2: Patients without local therapy in the retroperitoneum
| Histology | Stage | Therapy | Recurrence rate (%) | Occurrence of recurrence |
|---|---|---|---|---|
| Seminoma | I | Carbo monotherapy | 3–5 | Years 1–3b |
| Seminomaa | IIB/IIC/III (good prognosis) | 3× PEB/4 EP | 11–18 | Years 1–4 |
| Non-seminomatous GCT | I high risk | 1× PEB (or 2× PEB according to the former recommendation) |
3–5 | Years 1–5 |
| Non-seminomatous GCT | IIA/B/IIC/III (good prognosis) | 3× PEB | 8–18 | Years 1–3 |
a
Complete remission or residual tumour <3 or >3 cm, PET negative.
b
15% of seminoma recurrences still occur after the 3rd follow-up year.